Dose of midazolam should be reduced during diltiazem and verapamil treatments (Q34346089)

1 August 2017

title

Dose of midazolam should be reduced during diltiazem and verapamil treatments (English)

1 reference

1 August 2017

1 reference

1 reference

Backman JT

1

1 reference

1 August 2017

Olkkola KT

2

1 reference

1 August 2017

Aranko K

3

1 reference

1 August 2017

Himberg JJ

4

1 reference

1 August 2017

Neuvonen PJ

5

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 March 1994

1 reference

British Journal of Clinical Pharmacology

1 August 2017

published in

1 reference

1 August 2017

volume

37

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

221-225

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364750

1 August 2017

1 reference

Measurement of Recovery from Outpatient General Anaesthesia with a Simple Ocular Test

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364750

Inhibition of hepatic microsomal drug metabolism by the calcium channel blockers diltiazem and verapamil

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364750

Cimetidine and ranitidine increase midazolam bioavailability.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364750

The usefulness of radioreceptor assay and gas liquid chromatography in pharmacokinetic studies on midazolam.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364750

Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364750

In vitro forecasting of drugs which may interfere with the biotransformation of midazolam

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364750

Pharmacokinetic Interactions with Calcium Channel Antagonists (Part I)1

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364750

A potentially hazardous interaction between erythromycin and midazolam.

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1994.TB04266.X

Pencil and paper tests-sensitivity to psychotropic drugs

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1994.TB04266.X

Liquid-chromatographic quantification compared with gas-chromatographic-mass-spectrometric determination of verapamil and norverapamil in plasma

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8198928

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

High-performance liquid chromatographic determination of diltiazem and four of its metabolites in plasma: evaluation of their stability

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8198928

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Changes in antipyrine and indocyanine green kinetics during nifedipine, verapamil, and diltiazem therapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8198928

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2125.1994.TB04266.X

1 reference

1 August 2017

1 reference

1 August 2017

1 reference